AKT1 and tongue cancer: Although not explored in detail in this study, as reinforced by previous findings, PN2 may confer chemotherapy resistance to tongue cancer cells via Akt activation as a cell survival signal, promoting the proliferation, invasion, and metastatic potential of TSCC.